Physician

Srinivas Kottapally, M.D.

According to 2025 Medicare claims, Srinivas Kottapally, M.D. (NPI: 1962404343) practices radiation oncology in the Pittsburgh, PA market, with the plurality of this provider's patient population coming from Fayette, PA. This provider's primary affiliated billing organization is FAYETTE ONCOLOGY ASSOCIATES (NPI: 1003817958; TIN: 582678171) and primary practice location at 15401-8400.

Kottapally's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 93 traditional Medicare patients, billed 2,588 HCPCS/CPT codes, and received $415,831 in Medicare payments. The top billing code was 77427 (Radiation treatment management, 5 treatment sessions). Part D data shows 71 prescription claims across 46 beneficiaries totaling $3,994 in drug costs, led by Bicalutamide (Bicalutamide). Open Payments data shows 1 records totaling $15. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $1,287 and ending at $3,994. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$314K$627K2015 Medicare payment: $335,753 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $592,435 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $495,180 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $502,713 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $561,778 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $627,010 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $342,323 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $365,990 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $383,425 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $415,831 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151182,205$335,753
20161304,063$592,435
20171203,390$495,180
20181233,388$502,713
20191163,494$561,778
20201244,027$627,010
20211002,203$342,323
2022922,296$365,990
2023902,630$383,425
2024932,588$415,831

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$2.0K$4.0K2015 Drug cost: $1,287 (USD; Tot_Drug_Cst)2016 Drug cost: $1,289 (USD; Tot_Drug_Cst)2017 Drug cost: $1,740 (USD; Tot_Drug_Cst)2018 Drug cost: $1,680 (USD; Tot_Drug_Cst)2019 Drug cost: $947 (USD; Tot_Drug_Cst)2020 Drug cost: $835 (USD; Tot_Drug_Cst)2021 Drug cost: $1,894 (USD; Tot_Drug_Cst)2022 Drug cost: $731 (USD; Tot_Drug_Cst)2023 Drug cost: $777 (USD; Tot_Drug_Cst)2024 Drug cost: $3,994 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20154371$1,287
20163780$1,289
201754127$1,740
20185182$1,680
20193561$947
20202652$835
20213365$1,894
20223054$731
20234666$777
20244671$3,994

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
77427Radiation treatment management, 5 treatment sessions52201$143
77263Complex radiation therapy planning5152$127
77334Design and construction of complex radiation treatment device4498$93
77336Continuing radiation therapy consultation per week49175$64
77300Calculation of radiation therapy dose52261$49

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
BicalutamideBicalutamide15410$179
Tamsulosin HclTamsulosin Hcl15840$118
Silver SulfadiazineSilver Sulfadiazine18369$115

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.1$15Boston Scientific Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Srinivas Kottapally, M.D.?

Tedicare shows public-source Medicare data for Srinivas Kottapally, M.D. (NPI 1962404343), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Srinivas Kottapally, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Srinivas Kottapally, M.D.?

Srinivas Kottapally, M.D. is linked to FAYETTE ONCOLOGY ASSOCIATES (billing NPI 1003817958) in the available physician profile data.

Does Srinivas Kottapally, M.D. have Open Payments data?

Srinivas Kottapally, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.